Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
Clinical trial NCT00189904 · COMPLETED
Trial details
- NCT number
- NCT00189904
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.